The addition of 2-bromobenzylmagnesium bromide to chiral N-tert-butanesulfinyl imines derived from tetralone type ketones proceeds with high levels of diastereocontrol. The resulting sulfinamide derivatives were transformed into dibenzoazaspiro compounds after a palladium catalyzed intramolecular N-arylation. DFT calculations have been performed to rationalize the stereochemical course of the reaction. Similar results have been obtained considering either diethyl ether or toluene as a solvent, in both cases in an excellent agreement with experimental findings. NCI topological calculations have also been used to evidence crucial noncovalent interactions. In addition, the azaspiro compounds reduced the viability chronic myeloid leukemia cells in the micromolar range. Notably, both the halogen-substituted (R)and (S)-8g and 8h as well as (R)-8j were at least two times more effective on a multidrug-resistant derivative than on the parental cell line, exerting a collateral sensitivity effect.
. Representative natural products bearing the 1-azaspiro [4.5] 
decane unit
Being aware of the potential interest of dibenzo 1-azaspiro [4.5] decane derivatives with regard to antimitotic effect targeting the cytoskeleton, our interest in the study of the nucleophilic additions to N-tert-butanesulfinyl imines, and the influence of the stereogenic center on the stereochemical outcome of these reactions, we herein report our approach to the synthesis of these compounds through a successive addition of an organomagnesium compound to the corresponding chiral tertbutanesulfinyl imine and final intramolecular N-arylation (Scheme 1). Since the addition of Grignard reagents to these chiral imines proceeds in a diastereoselective manner, the two possible enantiomers are accessible by starting from the corresponding (R S )-or (S S )-sulfinyl imine. It is worth mentioning that chiral N-tert-butanesulfinyl imines 14 have attracted great attention for their potential uses in the stereoselective synthesis of amine derivatives containing a stereogenic center bonded to the nitrogen atom. For example, Chuang and co-works employed sulfinyl imine and organolithium in the synthesis of 3-demethoxyerythratidinone (4) (Figure 1) 15 . With regards to this, we have studied the stereoselective addition to these imines of different reagents, such as allyl 16 and propargyl 17 indium bromides in the presence of indium metal, nitrocompounds, 18 enolates 19 and Grignard reagents. 20 Scheme 1. Retrosynthetic analysis of synthesis of dibenzo 1-azaspiro [4.5] 
decane derivatives

RESULTS AND DISCUSSION
Synthetic studies
The synthesis of the target dibenzo 1-azaspiro [4.5] decanes started with the diastereoselective addition of 2-bromobenzylmagnesium bromide (5) to the corresponding chiral N-tert-butanesulfinyl imine (4) . Chiral imines 4 were easily accessible by condensation of enantiomerically pure tertbutanesulfinamide 1, and the corresponding tetralone (2a-h; X = CH 2 or CHMe; R = H, MeO, F, Br) , chromanone (2i; X = O; R = H) , or thiochromanone (2j; X = S; R = H) derivative in the presence of titanium tetraethoxide. The addition of Grignard reagents to N-tert-butanesulfinyl imines was studied for the first time by Ellman and co-workers and showed a remarkable dependence of diastereoselectivity using coordinating or non coordinating solvents, the best results being obtained in non coordinating solvents. 21 It was found that the attack of the Grignard reagent occurred on the Si-face of the imine with the R configuration at the sulfur atom. In previous studies, we observed that the highest diastereoselectivities in the addition of organomagnesium compounds to N-tert-butanesulfinyl imines were obtained in toluene and the lowest diastereoselectivities were reached in THF as solvent. 20 Based on that, we studied the reaction of a 1 M solution of 2bromobenzylmagnesium bromide (5) in ether to the corresponding imine 4 in toluene ( Table 1 ). The addition was carried out at -78 ºC, and after that the reaction was allowed to reach room temperature. Organomagnesium compound 5 was prepared from 2-bromobenzyl bromide (3) and magnesium powder, and in all cases, complete conversion was observed using three equivalents of the Grignard reagent 5. The expected sulfinyl amine derivatives 6 were obtained in general in moderate yields. The highest yield was found for (R S )-6i (92%), resulting from the addition of 5 to the imine 4i derived from chromanone (2i) and (R)-tert-butanesulfinamide [(R)-1]. On the other hand, the imine 4a was the model substrate that we took to study these transformations, and yield shown on Table 1 for compound (R S )-6a corresponds to the highest yield we obtained after several reactions. The reaction conditions were not optimized for the rest of imines 4, neither the reactions 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   Table 1 . Diastereoslective addition of 2-bromobenzylmagnesium bromide (5) to chiral imines 4 a,b a Reactions were carried out starting from 1.0 mmol of the corresponding imine 4 in 5 mL of toluene. b Isolated yields after column chromatography purification. Diastereomeric ratios are given in parenthesis and were determined from 1 H-NMR spectrum of the crude reaction mixture.
Finally, target spiro compounds 8 were obtained from benzyl amine derivatives 6 through a sequential removal of the tert-butanesulfinyl group under acidic conditions, and subsequent 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 intramolecular N-arylation of the resulting free amine 7 under palladium catalysis, using Cs 2 CO 3 as a base in toluene, in a high pressure tube at 110 ºC for 20 hours (Table 2) . Spiro compounds 8 were isolated in an enantiomerically pure form in yields ranging from 50% to 70% in most of the cases. Table 2 . Synthesis of spiro compounds 8 through a sequential desulfinylation and intramolecular Narylation a,b a Reactions were carried out starting from 0.5 mmol of the corresponding compound 6. b Isolated yields after column chromatography purification.
Theoretical studies
We performed density-functional theory (DFT) calculations in order to understand the origins of the stereocontrol of the reaction between imines 4 and 2-bromobenzylmagnesium bromide (5) . The nucleophilic addition reaction was studied at b3lyp-d3bj/def2svp level of theory to calculate geometries and then single point calculations at b3lyp-d3bj/def2tzvp/pcm=diethylether level of theory were performed for obtaining more accurate energy values; calculations in toluene were also performed for the purpose of comparison (for details see SI). Since the reaction was performed in a mixture of toluene-diethyl ether discrete molecules of dimethyl ether were added to complete the tetrahedral coordination sphere of magnesium when necessary. It has been reported that four-membered rings formed through a Schlenk equilibrium control Grignard reactions, 23 but the presence of coordinating solvent molecules can displace the equilibrium towards the free Grignard reagent. 24 We have studied as a model reaction, the nucleophilic addition of Grignard reagent 5 to imine 4a (R = H, X =CH 2 ) as illustrated in Scheme 2). Scheme 2. General mechanism for the reaction between 4a and 5
Admittedly, nucleophilic additions of organometallic reagents, like Grignard reagents, to unsaturated systems capable of complexing the metal atom usually start with the formation of an initial complex. Typical examples are Grignard additions to carbonyl compounds 25 and nitrones. 26 In the particular case of sulfinyl imines, the sulphoxide group can displace a solvent molecule and form the initial complex CP as reported by Eisenstein and co-workers. 27 Although the (E)-imine is more stable than the (Z)-imine (by 5.1 kcal/mol), there is a rapid equilibrium between both isomers of sulfinyl imines 27 so, in agreement to Curtin-Hammett's principle, 28 the participation of the (Z)isomer cannot be discarded a priori. In consequence, to locate possible transition structures TS we defined approaches for (E)-and (Z)-imines by Re and Si faces in which two possible orientations of the aryl Grignard reagents are possible due to the presence of the bromine atom, thus being a total of eight approaches leading to the two different diastereoisomers that can be obtained ( Figure 2 ). 29 In the final products PRa,b, the magnesium atom is coordinated to both oxygen and nitrogen atoms of the sulfinyl amino group in agreement with previous studies. 27 The analysis of the eight located transition structures TSa-h revealed that TSa, corresponding to the Grignard addition by the Si face of (E)-isomer and TSg, corresponding to the Grignard addition by the Re face of (Z)-isomer, present the lowest barriers with values of 14.3 and 15.4 kcal/mol, respectively (for the complete energy profiles see SI). A Boltzmann distribution corroborated that TSa and TSg are essentially the only representative transition structures, with a very minor contribution of TSh (see SI). This analysis, obtained considering diethyl ether as a solvent, predict an 80:20 diastereomeric ratio for the products. Similar results were observed when toluene was considered as a solvent (13.8 and 15.0 kcal/mol for TSa and TSg, respectively), the corresponding Boltzmann distribution predicting a diastereomeric ratio of 83:17. These results are in a very good agreement with the experimentally observed 90:10 diastereomeric ratio. The analysis of the optimized geometries of the transition structures revealed interesting features that justify the observed differences in energies. For the geometrical analysis we have only considered the most stable transition structure for each attack i.e: TSa and TSc for Si attacks to (E)and (Z)-isomers, respectively, and TSe and TSg for Re attacks to (E)-and (Z)-isomers, respectively ( Figure 3 ). The transition structure TSa (Si-attack to (E)-isomer) corresponding to the lowest barrier, presents important London interactions between the two aromatic rings without remarkable steric requirements. On the other hand, TSe, corresponding to the attack by the other face of the same isomer is 9.1 kcal/mol higher in energy, despite the presence of CH-π and halogen-π interactions. The reason of such a difference is a steric clash between the entering benzyl group and the tert-butyl group, which causes a severe steric hindrance. A similar situation but from a different scenario is found for the (Z)-isomer. The transition structure TSg, corresponding to the Re-attack and only 1.2 kcal/mol higher in energy than TSa, is the one that presents fewer favorable noncovalent interactions but it has practically no steric hindrance in the approach of the benzyl group to the imine carbon. On the contrary, TSc, showing the highest barrier and corresponding to the attack by the Si face, should modify the attack angle because of the presence of the fused cyclohexane that, though might give rise to CH-π interactions, it also causes steric difficulties for the attack. details see SI). As an example, Figure 4 illustrates such an analysis for TSa and TSe in which London and π-halogen interactions, respectively, are shown. 
Studies on cancer cells
The development of new chemotherapeutics must take a set of factors into account since cancer cells often present intrinsic and acquired mechanisms to evade cytotoxicity. Increased cytoskeleton remodelling to support cell motility, mitosis and protein trafficking is a cancer hallmark 31 and, after a chemotherapy regimen, drug resistance may emerge due to selective killing of sensitive cells. The multidrug resistance phenotype (MDR) manifests due to cross-resistance to chemotherapeutic drugs with no structural nor functional relationship, markedly by increased activity of ABC superfamily transporters. 32 In regard to this, and considering that the benzo-1-azaspiro [4.5] decane motif is described to present antimitotic properties, all compounds were screened for toxicity towards MDA-MB-231, a model of an invasive, poorly differentiated and endocrine therapy-resistant breast ductal carcinoma. Results indicated compounds (S)-8d, (S)-8g, (S)-8h, (S)-8i and (R)-8j as potential candidates for further studies, since they reduced cell viability to at least 50% after treatment with 100 μM for 72 h. Taken these results into account, these compounds, along with their respective (S)-or (R)-enantiomers, were further evaluated on two models of human chronic myeloid leukemias. K562 cells present constitutive BCR/ABL tyrosine kinase activity leading to a highly proliferative status; FEPS is a K562/DNR derivative cell selected after continuous exposure of K562 to daunorubicin (DNR), 33 cross-resistant to a variety of natural and synthetic compounds owing to, but not limited to, its high efflux activity mediated by the ABC transporters ABCB1 (Pgp) and ABCC1 (MRP1). 33, 34 The chemotherapeutic drugs vincristine (VCR), a tubulin-binding antimitotic alkaloid, and daunorubicin, a pro-oxidant, DNA-alkylating anthracycline were employed as controls. The antiproliferative effect of the various compounds on K562 and FEPS cells can be observed in Table 3 . Results indicate that the evaluated compounds exerted cytotoxicity to both cell subtypes, most notably the 7'-bromo ( seemed to induce two-fold higher toxicity, and limited to K562. Disruption of the mitotic spindle is a well-recognized mechanism exerted by chemotherapeutic drugs such as VCR and paclitaxel, 35 and kinesin spindle proteins (KSP), motor proteins involved in anterograde protein transport and mitosis, are important for correct centrosome and chromosome segregation. 36 Kinesins have already been linked to multidrug resistance, 37 and its inhibition induced cell death on drug-resistant ovarian cancer 38 and lymphomas. 39 Since the benzo-1-azaspiro [4.5] decane motif was demonstrated to inhibit the KSP KIF11, FEPS present increased gene expression of KIF1A and KIF21B over K562, 40 and halogen modifications of known KSP inhibitors were shown to increase bioavailability 41 and to overcome ABC transporter-mediated efflux 42 this mechanism seems feasible. Intererstingly, all compounds but the 6'-methoxyl (S)and (R)-8d and the chromane (S)-8i presented higher toxicity to the MDR cell FEPS than to the parental K562. This profile is known as collateral sensitivity, and can be described as a hypersensitivity towards secondary drugs that arises from the development of resistance towards an unrelated primary agent. 43 Figure 5 shows that compounds (S)and (R)-8g, (S)-8h and (R)-8j induced collateral sensitivity on FEPS, since they presented RR ≤ 0.5. 44 Of note, for the standard drugs VCR and DNR this ratio was higher than 2.0, indicative of drug resistance. Despite being poorly understood, mechanisms that govern collateral sensitivity may either rely on or be independent from MDR mechanisms. ATP depletion after a futile cycle of passive influx and active efflux of an ABCB1 transporter substrate, ABCC1-mediated extrusion of endobiotics such as glutathione, ROS production after metal-mediated redox cycling and perturbation of cellular bioenergetics and/or the plasma membrane fluidity were linked to collateral sensitivity. 45 Of note, the azaspiro compounds with the lowest RR presented a similar modification, the addition of the halogens fluorine or bromine. Halogenation has been previously linked to collateral sensitivity, as the addition of bromine, 46 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 interactions involving the carbonyl group present on the side chain of every aminoacid, and carboxylates in aspartate and glutamate. 48 Whether the observed collateral sensitization is a result of KSP inhibition, interaction with (or lack thereof) ABC proteins, targeting aminoacids such as the glutathione precursor glutamate, of simply by the increased bioavailability granted by the addition of halogens, this effect should undergo thorough investigation as it could foster the development of MDR-targeting azaspiro compounds.
CONCLUSIONS
Dibenzo-1-azaaspiro [4.5] decanes were prepared in a enantiomerically pure form from tertbutanesulfinamide, 2-bromobenzylbromide and tetralone type ketones. The methodology presented here comprised as key steps a diastereoselective addition of a benzylic organomagnesium compound to a chiral sulfinyl ketimine and an intramolecular palladium-catalyzed N-arylation. DFT calculations correctly predicted the observed experimental results evidencing that the reaction is under kinetic control and the two competitive transition structures resulted from the Si attack to the (E)-isomer and the Re attack to the (Z)-isomer. Whereas in the former, the preferred one, the presence of stabilizing London interactions contributes to the lowest barrier, in the latter it is the absence of any steric hindrance which causes the corresponding barrier to be only 1.2 kcal/mol higher in energy. The benzo-1-azaspiro [4.5] decane derivatives were effective on models of leukemias with diverse adaptations to evade cytotoxicity, depending on the pattern of substitutions on its molecular scaffold. The thiochromane compounds were the most promising, whereas the addition of bromine or fluorine produced collateral sensitivity to MDR cells. Our results highlight the azaspiro motif as an important lead for the development of new antineoplastic drugs targeted to chemo-refractory neoplasias, a sought after profile for the management of cancer.
EXPERIMENTAL SECTION
General Remarks: tert-Butanesulfinamides (R and S) were a gift of Medalchemy (> 99% ee by chiral HPLC on a Chiracel AS column, 90:10 n-hexane/i-PrOH, 1.2 mL/min, λ=222 nm). TLC was performed on silica gel 60 F 254 , using aluminum plates and visualized with phosphomolybdic acid (PMA) stain. Flash chromatography was carried out on handpacked columns of silica gel 60 (230-400 mesh). Melting points are uncorrected. Optical rotations were measured using a polarimeter with a thermally jacketted 5 cm cell at approximately 20 ºC and concentrations (c) are given in g/100 mL. Infrared analyses were performed with a spectrophotometer equipped with an ATR component; wavenumbers are given in cm -1 . Low-resolution mass spectra (EI) were obtained at 70 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 eV; and fragment ions in m/z with relative intensities (%) in parentheses. High-resolution mass spectra (HRMS) were also carried out in the electron impact mode (EI) at 70 eV using a quadrupole mass analyzer or in the electrospray ionization mode (ESI) using a TOF analyzer. NMR Spectra were recorded at 300 or 400 MHz for 1 H NMR and 75 or 100 MHz for 13 C NMR, using CDCl 3 and CD 3 OD as the solvents, and TMS as internal standard (0.00 ppm). 19 min. After cooling to room temperature, the mixture was diluted with EtOAc (10 mL) and poured into 0.5 mL of brine while being rapidly stirred. The resulting suspension was filtered through a plug of Celite, and the filter cake was washed with EtOAc (20 mL). After evaporation of the solvent (15 Torr) , the residue was purified by column chromatography (silica gel, hexane/EtOAc) to yield products 4a-h. Yields, physical and spectroscopic data follow. 49 The representative procedure was followed by using tetralone 2a (731.0 mg, 0.665 mL, 5.00 mmol) and ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 (1:1); yellow oil; R f = 0.67 (hexane/EtOAc, 1:1); IR ν (neat) 2959, 1685, 1456, 1360, 1294, 1159, 1072, 1054, 1011, 764, 721, 690 (100), 147 (13), 57 (10). 49 The representative procedure was followed by using 6-methoxytetralone 2d (883.0 mg, 5.00 mmol) and (15), 175 (100), 147 (39), 57 (10). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (29), 145 (23), 57 (17) . (22), 176 (23), 159 (19), 57 (13). (48), 223 (50), 57 (38) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 (S S )-4h (760.0 mg, 2.85 mmol, 78%). Physical and spectroscopic data were found to be same than for (R S )-4j.
(R S )-N-(tert-Butanesulfinyl)-3,4-dihydronaphthalen-1(2H)-imine [(R S )-4a]:
[α] D 20 = +89.2 (c = 0.34, CH 2 Cl 2 ).
General Procedure for the Reaction of 2-Bromobenzylmagnesium Bromide ( (1.0 mmol) in dry toluene (4 mL) was added dropwise a 1M solution of 2-bromobenzylmagnesium bromide (5) in diethyl ether (3.0 mmol, 3.0 mL) at -78 ºC. The reaction mixture was allowed to reach room temperature for 12 h, and after that, it was cooled down to 0 ºC, hydrolyzed with water (5 mL) and extracted with EtOAc (4 × 15 mL). The organic layers were successively washed with water (15 mL), brine (10 mL) and then dried with anhydrous MgSO 4 , and the solvent evaporated (15 Torr) . The residue was purified by column chromatography (silica gel, hexane/EtOAc) to yield products 6. Yields are given on Table 1 , physical and spectroscopic data follow. 1S,4R*)-1-(2-Bromobenzyl)-N-(tert-butanesulfinyl)-4-methyl-1,2,3,4- 
tetrahydronaphthalen-1-amine [(R S )-6b]:
The representative procedure was followed by using imine (R S 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (45), 169 (47), 144 (29) , 143 (44), 131(53), 57 (40); HRMS (ESI-TOF) m/z:
(M+H) + Calcd for C 22 H 29 BrNOS 434.1153; Found 434.1144 . 1S)-1-(2-Bromobenzyl)-N-(tert-butanesulfinyl)-5-methoxy-1,2,3,4-tetrahydronaphthalen (22), 329 (100), 280 (27), 224 (58), 175 (38) , 171 (38) , 169 (40), 159 (46), 147 (78), 121 (40) , 57 (24) 1S)-1-(2-Bromobenzyl)-N-(tert-butanesulfinyl)-7-methoxy-1,2,3,4 -tetrahydronaphthalen-1amine [(R S )-6e]: The representative procedure was followed by using imine (R S )-4e (397.0 mg, 1:1), IR ν (neat) 2943, 2865, 1734, 1466, 1266, 1236, 1040, 761, 732 cm -1 ; δ H 7.57 (d, J = 8. ,1S)-1-(2-Bromobenzyl)-N-(tert-butanesulfinyl)-6,7-dimethoxy-1,2,3,4 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 127.1 (CH), 126.5 (C), 123.5 (CH), 60.44 (C), 57.23 (C), 46.95 (CH 2 ), 37.24 (CH 2 ), 23.50 (CH 2 ,1R)-1-(2-Bromobenzyl)-N-(tert-butanesulfinyl)-1,2,3,4 mg, 1.24 mmol, 75%). Physical and spectroscopic data were found to be same than for (R S )-6g.
[α] D 20 = +50.6 (c = 0.64, CH 2 Cl 2 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 (S S ,1R)-7-Bromo-1-(2-bromobenzyl)-N-(tert-butanesulfinyl)-1,2,3,4-tetrahydronaphthalen-1amine [(S S )-6h]: The representative procedure was followed by using imine (S S )-4h (317.0 mg, 0.96 mmol). Purification by column chromatography (hexane/AcOEt, 2:1) yielded (S S )-6h (282.2 mg, 0.57 mmol, 60%). Physical and spectroscopic data were found to be same than for (R S )-6h.
[α] D 20 = +47.7 (c = 0.54, CH 2 Cl 2 ). Physical and spectroscopic data were found to be same than for (R S 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 (hexane/AcOEt, 20:1) yielded (S)-8j (58.3 mg, 0.23 mmol, 72%). Physical and spectroscopic data were found to be same than for (R)-8j.
[α] D 20 = +49.4 (c = 0.98, CH 2 Cl 2 ).
Cell Culture Methods
The chronic myeloid leukemia cell lines K562 and FEPS were cultured in RPMI-1640 medium (Sigma-Aldrich, St Louis, MO, USA) supplemented with 25 mM HEPES adjusted to pH 7.4 with NaOH, 60 mg.L -1 penicillin and 100 mg.L -1 streptomycin (all obtained from Sigma-Aldrich). Dr.
Vivian M. Rumjanek kindly donated FEPS cells. Briefly, K562 cells were exposed to increasing concentrations of the chemotherapeutic drug daunorubicin hydrochloride (DNR) (Sigma-Aldrich), as described before 32 . FEPS (K562/DNR) cells were cultured in the presence of 500 nM DNR in order to maintain the MDR phenotype. For subcultures, cells were harvested every three days followed by washing with cold phosphate-buffered saline, and maintained at 37 ºC in 5% CO 2 . All media was supplemented with 10% fetal bovine serum (FBS) (Thermo Fischer Scientific, Waltham, MA, USA) inactivated at 56 °C for 1 h prior to use.
In vitro cell viability
Cell viability was determined with the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium (MTT; Sigma-Aldrich). Prior to the experiments, the MDR FEPS cells were cultured free of DNR to avoid additive effect. Briefly, 10 4 mL -1 leukemia cells were treated with compounds at a range of concentrations and incubated for 72 h at 37 ºC. Negative controls were prepared with DMSO 0.1% (Vetec Química Fina, Duque de Caxias, RJ, Brasil), and positive ones with VCR or DNR. Then, media was replaced with fresh RPMI supplemented with 10% FBS, 20 μL MTT (5 mg.mL -1 ) was added to each well and plates were kept at 37 °C in 5% CO 2 for 3 h.
Plates were then centrifuged, and 200 μL DMSO was added to dissolve the formazan crystals . When IC 50 exceeded the maximal tested concentration it was expressed as being higher than this concentration (e.g. >200), and this value, 200, was used for calculating the RR (e.g. RR of (R)-8i: IC 50 FEPS / IC 50 K562 = 154.83/200 = 0.77) . If RR ≤ 0.5, the compound exerted collateral sensitivity 44 , and cells were considered resistant when RR ≥ 2.0.
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